top of page



FDA Plans to Phase Out Animal Testing Requirement
The FDA is considering phasing out animal testing for drug development, marking a significant step towards modernizing outdated regulations.
4 days ago4 min read

First Full-Spectrum Cannabinoid Drug Seeking FDA Approval to Treat ASD
AJA001, a botanical drug for autism spectrum disorder (ASD), showed positive Phase 1 trial results. Phase 2 trials are set for mid-2025. AJA
Jan 312 min read

How one company filed a marketing authorization in Europe for a botanical drug to treat alopecia areata
Many early pharmaceutical drugs, including codeine, quinine, and digoxin, were derived from plants. While traditional drug development...
Oct 26, 20242 min read

Fermentation: improvement of pharmacological effects and applications of botanical drugs
Fermentation is an important concoction technique for botanical drugs. Fermentation transforms and enhances the active ingredients of botani
Oct 26, 202436 min read

Pharmaceutical Giants Brace for Revenue Plunge as Blockbuster Drug Patents Near Expiry
As the top 20 biopharma companies collectively have a staggering $180 billion in sales at risk due to patent expiration slated to occur arou
Jan 31, 20243 min read


A Clinical Trial Showed that a TCM Product Reduced Heart Failure Hospitalizations
The TCM qiliqiangxin reduces hospitalization for heart failure and cardiovascular death in patients with heart fail
Jan 19, 20243 min read


A plant-based, oral delivery of insulin regulates blood sugar levels similar to natural insulin
A plant-based, oral delivery of proinsulin lowers the risk of hypoglycemia when compared to current diabetes treatments, according to a new
Jan 16, 20243 min read

British American Tobacco Invests $10 Million in the Hemp Industry to Develop Botanical Drugs
British American Tobacco (BAT), a major player in the global cigarette market, made a surprising move by announcing a significant...
Jan 13, 20242 min read

Chiesi Global Rare Diseases Announces FDA Approval of FILSUVEZ® for Epidermolysis Bullosa Wounds
FDA has granted approval for FILSUVEZ®, a topical gel containing birch triterpenes, designed to address the treatment of partial thickness w
Dec 31, 20232 min read


ABDA Partnership Launches Digital HPLC Database to Elevate Botanical Drug Standards
The American Botanical Drug Association (ABDA) is advancing an unprecedented initiative through its affiliated analytical laboratory,...
Dec 15, 20232 min read


Maye Musk Inspires at a Hong Kong Entrepreneur Event
Maye Musk, the renowned model, dietitian, and mother of entrepreneur Elon Musk, added star power to a high-profile entrepreneur gathering by
Dec 11, 20231 min read

OnTarget Study Innovates Cancer Therapy-Related Diarrhea Management with Crofelemer
Napo Pharmaceuticals's pivotal phase 3 OnTarget trial for prophylaxis of diarrhea in adult cancer patients is a 12-week trial targets cancer
Nov 15, 20232 min read

FDA Approves NexoBrid, a Revolutionary Topical Gel for Burn Care
In what is being hailed as a major advancement in the field of burn care, the U.S. Food and Drug Administration (FDA) has recently...
Oct 26, 20232 min read


RCT: Traditional Chinese Medicine Compound (Tongxinluo) for Acute Myocardial Infarction
In patients with ST-segment elevation myocardial infarction (STEMI), the traditional Chinese medicine Tongxinluo, as an adjunctive therapy
Oct 25, 20232 min read

Botanical Drug for the Treatment of Alopecia Areata in Children
At the forefront of groundbreaking research, Coacillium, a plant-based drug developed by Legacy Healthcare, has emerged as a potential...
Sep 26, 20231 min read


Botanical drug clinical trial: common issues and future options
Abstract: botanical drug clinical trials registered at ClinicalTrial.gov were analyzed. Trends in current trials were discovered and guide f
Aug 31, 20238 min read

Alphyn Biologics Phase 2a Trial for Atopic Dermatitis with Secondary Bacterial Infection
Alphyn Biologics, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics, released interim results...
Jul 21, 20232 min read

Sinoveda's Botanical Drug Approach to Treat Long Covid
Sinoveda is a health brand that is bringing innovative, herbally-based precision to drug discovery. The company's research team, led by...
Jul 21, 20231 min read

CASE STUDY: Mytesi
A showcase of the first botanical drug approved by the US FDA for treating diarrheal caused by HIV/AIDS antiretroviral therapy, about the wh
Jul 15, 20231 min read

Napo Pharmaceuticals Submits Investigational New Drug (IND) Application to FDA
Napo Pharmaceuticals Inc announced the submission of an IND application to the U.S. FDA for a new crofelemer powder for oral solution formul
Jul 12, 20232 min read


Baptist University Advanced a Botanical Drug to Phase I
Hong Kong Baptist University is set to conduct the first phase of clinical trials for a novel Chinese medicine targeting chronic constipatio
Jun 10, 20232 min read

REHEVA BIOSCIENCES ANNOUNCES FIRST PATIENT ENROLLED IN RH324 PHASE I SAFETY TRIAL
ReHeva Biosciences is announcing the first patient enrolled and dosed in the Phase I Safety Trial for the company's drug, RH324.
Jun 8, 20221 min read

Paper: Coronavirus disease 2019: The prospect for botanical drug’s polymolecular approach
by Dr. Andre Boultet, Chairman and CEO of Devonian Health Group, Canada's largest botanical drug company ABSTRACT Coronavirus disease...
Nov 22, 20211 min read

A public known TCM formula opens phase 1 enrollment for US FDA botanical drug IND
In 2020, a joined force by UCLA, USC, UCSD was formed to develop scientific data on a well-known Chinese herbal medicine formula, Qing...
Sep 27, 20211 min read
Yeast probiotic designed to treat diarrhea and strengthen healthy digestive and immune systems
“Saccharomyces boulardii (S. boulardii) is a kind of probiotic that has been considered a crucial nutritional intervention in treating...
Sep 8, 20211 min read

Yiviva Advances its Botanical Cancer Drug into the Clinical Development
Yiviva, a pharmaceutical company focused on developing botanical drugs, has moved its lead candidate further into an international phase...
Jul 30, 20211 min read
Tetra Bio-Pharma To Monetize Its Dronabinol And Botanical Product Portfolios
Subject to registration with the European Medicines Agency (EMA), DanCann Pharma will handle the exclusive sales and distribution in the...
Mar 1, 20212 min read
Brilacidin Received FDA IND Approval for Phase 2 Trial for Covid-19
Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company developing Brilacidin, a Host Defense Protein...
Dec 22, 20201 min read

Mytesi is in development for follow-on indications including Covid-19 induced diarrhea
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") and the Company's wholly-owned subsidiary, Napo Pharmaceuticals, Inc....
Nov 30, 20202 min read


GW Pharma Develops a Botanical Drug to Treat Multiple Sclerosis
California-based GW said it will launch the first Phase III trial studying nabiximols, which is known as Sativex outside the United...
Nov 10, 20202 min read
Industry News
bottom of page